Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 16857250)

Published in Gynecol Oncol on July 18, 2006

Authors

Tetsuro Yahata1, Nobumichi Nishikawa, Yoichi Aoki, Kenichi Tanaka

Author Affiliations

1: Department of Obstetrics and Gynecology, Niigata University School of Medicine, 1-757 Asahimachi-Dori, Niigata, Japan. yahatat@med.niigata-u.ac.jp

Articles by these authors

MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom (2010) 6.16

Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun (2002) 3.41

The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat Cell Biol (2002) 2.40

Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J Endocrinol (2006) 1.64

Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets. PLoS One (2010) 1.58

High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Clin Cancer Res (2012) 1.56

Rupture of pseudoaneurysm after vaginal delivery successfully treated by selective arterial embolization. Arch Gynecol Obstet (2009) 1.53

Cigarette smoking and glutathione S-transferase M1 polymorphism associated with risk for uterine cervical cancer. J Obstet Gynaecol Res (2008) 1.47

Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet (2012) 1.42

Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg (2009) 1.41

Acute changes in home blood pressure after the Great East Japan Earthquake among patients with chronic kidney disease in Fukushima City. Clin Exp Nephrol (2012) 1.40

Elevated serum CA125 and CA19-9 due to the spontaneous rupture of ovarian endometrioma. Eur J Obstet Gynecol Reprod Biol (2002) 1.38

Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule. Gynecol Oncol (2012) 1.32

Genome-wide expression of azoospermia testes demonstrates a specific profile and implicates ART3 in genetic susceptibility. PLoS Genet (2008) 1.28

Results of EPR dosimetry for population in the vicinity of the most contaminating radioactive fallout trace after the first nuclear test in the Semipalatinsk test site. J Radiat Res (2006) 1.27

Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J Exp Clin Cancer Res (2008) 1.26

Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination. Int J Clin Oncol (2014) 1.23

Predicting time to ovarian carcinoma recurrence using protein markers. J Clin Invest (2013) 1.17

Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. Cancer Sci (2009) 1.12

Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol (2010) 1.08

Effects of sunlight exposure on the human tooth enamel ESR spectra used for dose reconstruction. J Radiat Res (2006) 1.07

Morphobase, an encyclopedic cell morphology database, and its use for drug target identification. Chem Biol (2012) 1.05

Metabolomics approach for determining growth-specific metabolites based on Fourier transform ion cyclotron resonance mass spectrometry. Anal Bioanal Chem (2008) 1.04

Resolution of uterine arteriovenous malformation and successful pregnancy after treatment with a gonadotropin-releasing hormone agonist. Obstet Gynecol (2011) 1.04

Estimation of beta-ray skin dose from exposure to fission fallout from the Hiroshima atomic bomb. Radiat Prot Dosimetry (2011) 1.03

Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer. Gynecol Oncol (2004) 1.03

Radiation dose estimation by tooth enamel EPR dosimetry for residents of Dolon and Bodene. J Radiat Res (2006) 1.01

Germline copy number variations in BRCA1-associated ovarian cancer patients. Genes Chromosomes Cancer (2010) 1.01

Estimation of β-ray dose in air and soil from Fukushima Daiichi Power Plant accident. J Radiat Res (2014) 1.00

Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev (2007) 0.98

Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population. J Hum Genet (2010) 0.98

Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary. Gynecol Oncol (2007) 0.97

Tooth enamel EPR dosimetry: optimization of EPR spectra recording parameters and effect of sample mass on spectral sensitivity. J Radiat Res (2005) 0.97

Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer. Int J Clin Oncol (2015) 0.97

A case of congenital high airway obstruction syndrome managed by ex utero intrapartum treatment: case report and review of the literature. Am J Perinatol (2007) 0.96

Heparanase expression and angiogenesis in endometrial cancer. Gynecol Obstet Invest (2003) 0.96

Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Gynecol Oncol (2007) 0.95

ESR dosimetry study on population of settlements nearby Ust-Kamenogorsk city, Kazakhstan. Radiat Environ Biophys (2009) 0.94

Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer. Anticancer Res (2006) 0.94

Gamma-ray exposure from neutron-induced radionuclides in soil in Hiroshima and Nagasaki based on DS02 calculations. Radiat Environ Biophys (2008) 0.93

Surgical principles for managing stage IB2, IIA2, and IIB uterine cervical cancer (Bulky Tumors) in Japan: a survey of the Japanese Gynecologic Oncology Group. Int J Gynecol Cancer (2014) 0.93

Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma. Int J Clin Oncol (2013) 0.93

Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy: a Phase II Study of the Japanese Gynecologic Oncology Group. Jpn J Clin Oncol (2008) 0.93

Effects of uncoupling protein 1 and beta3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women. Maturitas (2003) 0.93

A gradient of radioactive contamination in Dolon village near the SNTS and comparison of computed dose values with instrumental estimates for the 29 August, 1949 nuclear test. J Radiat Res (2006) 0.91

Analysis of the complications after radical hysterectomy for stage IB, IIA and IIB uterine cervical cancer patients. J Obstet Gynaecol Res (2010) 0.90

Treatment and prognosis of brain metastases from gynecological cancers. Neurol Med Chir (Tokyo) (2008) 0.90

Seminal plasma inhibin-B level is a useful predictor of the success of conventional testicular sperm extraction in patients with non-obstructive azoospermia. J Obstet Gynaecol Res (2005) 0.90

Anatomical and histological profiling of orphan G-protein-coupled receptor expression in gastrointestinal tract of C57BL/6J mice. Cell Tissue Res (2009) 0.88

Preoperative Aspirin Use and Lung Injury After Aortic Valve Replacement Surgery: A Retrospective Cohort Study. Anesth Analg (2015) 0.88

Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer. Gynecol Oncol (2002) 0.88

Elective use of aortic balloon occlusion in cesarean hysterectomy for placenta previa percreta. Gynecol Obstet Invest (2008) 0.87

Thoracoscopic esophagectomy in the prone position for esophageal cancer with right aortic arch: case report. Anticancer Res (2013) 0.87

Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products. Scand J Clin Lab Invest (2012) 0.87

Concurrent chemoradiotherapy with paclitaxel and cisplatin for adenocarcinoma of the cervix. Anticancer Res (2012) 0.87

Outcome of pregnancy after laser conization: implications for infection as a causal link with preterm birth. J Obstet Gynaecol Res (2008) 0.86

Current surgical principle for uterine cervical cancer of stages Ia2, Ib1, and IIa1 in Japan: a survey of the Japanese Gynecologic Oncology Group. Int J Gynecol Cancer (2013) 0.86

Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1. AIDS (2006) 0.86

Abscess formation due to Mycoplasma hominis infection after cesarean section. J Obstet Gynaecol Res (2009) 0.86

Association of vitamin D and estrogen receptor gene polymorphism with the effects of longterm hormone replacement therapy on bone mineral density. J Bone Miner Metab (2004) 0.86

Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells. Fertil Steril (2006) 0.86

Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report. Am J Perinatol (2009) 0.86

Syndrome of inappropriate secretion of antidiuretic hormone induced by intraarterial cisplatin chemotherapy. Gynecol Oncol (2002) 0.86

Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival. Anticancer Res (2013) 0.85

Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066). Int J Gynecol Cancer (2012) 0.85

Concurrent chemoradiation for locally advanced squamous cell carcinoma of the vagina: case series and literature review. Int J Clin Oncol (2008) 0.85

Dysgerminoma with a slightly elevated alpha-fetoprotein level diagnosed as a mixed germ cell tumor after recurrence. Gynecol Obstet Invest (2003) 0.85

Staphylococcal scalded skin syndrome in an extremely low-birth-weight neonate: molecular characterization and rapid detection by multiplex and real-time PCR of methicillin-resistant Staphylococcus aureus. Pediatr Int (2011) 0.85

Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs. Clin Pharmacokinet (2004) 0.85

Growth retardation and death of rice plants irradiated with carbon ion beams is preceded by very early dose- and time-dependent gene expression changes. Mol Cells (2008) 0.85

Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer. Int J Clin Oncol (2010) 0.85

Comparative assessment of coagulation changes induced by two different types of heart-lung machine. Artif Organs (2009) 0.85

Advanced malignant rhabdoid tumor of the ovary effectively responding to chemotherapy: a case report and review of the literature. Gynecol Oncol (2007) 0.85

Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. Int J Mol Sci (2011) 0.84

Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes. Lipids Health Dis (2013) 0.84

Fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression. Gynecol Oncol (2003) 0.84

High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Anticancer Res (2011) 0.84

Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan. Gynecol Oncol (2005) 0.84

Delayed, massive bleeding as an unusual complication of laser conization. A case report. J Reprod Med (2003) 0.84

Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins. Gynecol Oncol (2003) 0.84

Studies on the compatibility of HLA-Class II alleles in patient couples with severe pre-eclampsia using PCR-RFLP methods. Am J Reprod Immunol (2008) 0.83

Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2005) 0.83

Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J). Hepatol Res (2014) 0.83

Studies on the prevalence of human papillomavirus in pregnant women in Japan. J Perinat Med (2006) 0.83

Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better. Gynecol Oncol (2005) 0.83

[A case of gallbladder metastasis from a malignant perivascular epithelioid cell tumor of the bladder]. Nihon Shokakibyo Gakkai Zasshi (2013) 0.83

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol (2010) 0.83

Microdosimetric evaluation of the 400 MeV/nucleon carbon beam at HIMAC. Med Phys (2005) 0.82

Microdosimetric evaluation of secondary particles in a phantom produced by carbon 290 MeV/nucleon ions at HIMAC. J Radiat Res (2007) 0.82

Microdosimetric study for secondary neutrons in phantom produced by a 290 MeV/nucleon carbon beam. Med Phys (2007) 0.82

Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma. Gynecol Oncol (2005) 0.82